Izražavanje enzima UGT2B4 pojačava farnezoidni X receptor (FXR), nuklearni receptor koji se aktivira žučnim kiselinama.[8] Ove iste žučne kiseline su supstrati za enzim UGT2B4. Otuda povećanje regulacije UGT2B4 aktiviranim FXR-om obezbeđuje mehanizam za detekciju, konjugaciju i naknadnu eliminaciju toksičnih žučnih kiselina.
^Monaghan G, Clarke DJ, Povey S, See CG, Boxer M, Burchell B (септембар 1994). „Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13”. Genomics. 23 (2): 496—9. PMID7835904. doi:10.1006/geno.1994.1531.CS1 одржавање: Формат датума (веза)
^Barre L, Fournel-Gigleux S, Finel M, Netter P, Magdalou J, Ouzzine M (март 2007). „Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33”. FEBS J. 274 (5): 1256—64. PMID17263731. S2CID27151203. doi:10.1111/j.1742-4658.2007.05670.x.CS1 одржавање: Формат датума (веза)
Ritter JK, Chen F, Sheen YY, et al. (1992). „Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives”. Biochemistry. 31 (13): 3409—14. PMID1554722. doi:10.1021/bi00128a015.
Fournel-Gigleux S, Jackson MR, Wooster R, Burchell B (1989). „Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyodeoxycholic acid in cell culture”. FEBS Lett. 243 (2): 119—22. PMID2492950. S2CID36610635. doi:10.1016/0014-5793(89)80111-5.
Monaghan G, Clarke DJ, Povey S, et al. (1995). „Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13”. Genomics. 23 (2): 496—9. PMID7835904. doi:10.1006/geno.1994.1531.
Jin CJ, Miners JO, Lillywhite KJ, Mackenzie PI (1993). „cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily”. Biochem. Biophys. Res. Commun. 194 (1): 496—503. PMID8333863. doi:10.1006/bbrc.1993.1847.
Babu SR, Lakshmi VM, Huang GP, et al. (1996). „Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites. pH stability and synthesis by human and dog liver”. Biochem. Pharmacol. 51 (12): 1679—85. PMID8687483. doi:10.1016/0006-2952(96)00165-7.
Monaghan G, Burchell B, Boxer M (1997). „Structure of the human UGT2B4 gene encoding a bile acid UDP-glucuronosyltransferase”. Mamm. Genome. 8 (9): 692—4. PMID9271674. S2CID31839619. doi:10.1007/s003359900539.
King CD, Rios GR, Assouline JA, Tephly TR (1999). „Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate”. Arch. Biochem. Biophys. 365 (1): 156—62. PMID10222050. doi:10.1006/abbi.1999.1155.
Lévesque E, Beaulieu M, Hum DW, Bélanger A (1999). „Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene”. Pharmacogenetics. 9 (2): 207—16. PMID10376768.
Strassburg CP, Kneip S, Topp J, et al. (2000). „Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine”. J. Biol. Chem. 275 (46): 36164—71. PMID10748067. doi:10.1074/jbc.M002180200.
Barbier O, Duran-Sandoval D, Pineda-Torra I, et al. (2003). „Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme”. J. Biol. Chem. 278 (35): 32852—60. PMID12810707. doi:10.1074/jbc.M305361200.
Saeki M, Saito Y, Jinno H, et al. (2005). „Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population”. Drug Metab. Dispos. 32 (9): 1048—54. PMID15319348.
Barre L, Fournel-Gigleux S, Finel M, et al. (2007). „Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33”. FEBS J. 274 (5): 1256—64. PMID17263731. S2CID27151203. doi:10.1111/j.1742-4658.2007.05670.x.